PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Esomeprazole - Acid Suppression (Children)

PAD Profile : Esomeprazole - Acid Suppression (Children)

Keywords :
reflux, GORD, gastro-oesophageal reflux disease, indigestion, PPI, Proton pump inhibitor, gastric acid, oesophagitis, gastro-resistant, enteral feeding tube
Brand Names Include :
Nexium

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Important
Formulations :
  • Granules
Important Information :
Branded Nexium granules for children/infants with enteral feeding tubes (6Fr or larger). Off-label use in infants under 1 year. Generic granules 3rd line in children/infants under 1 year without an NG tube. Refer to PPI algorithm for details.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves

GREEN Traffic light classification for.

  • Esomeprazole granules as branded product, Nexium® as an option in children and infants under the age of 1 with a NG tube >6 French (FR) in situ.(off-label use)
  • Generic esomeprazole granules may be prescribed (3rd line) for infants and children under the age of 1 without an NG tube in situ where the parents or carers are having difficulties in giving part-dose using orodispersible tablets.

This will need to be reviewed every 3 months as the child grows, to either discontinue treatment or change to the much less expensive orodispersible tablets described in the ‘PPIs for Children Prescribing Algorithm’ on the PAD

The APC note that the previous decisions made in December 2022 still stand:

  • omeprazole suspension in children under the age of 1 with a NG tube in situ, continues to have BLUE traffic light status
  • omeprazole suspension in children and infants under the age of 1 without an NG tube in situ, continues to have a NON-FORMULARY traffic light status
07 December 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed an algorithm for prescribing PPIs in children (see below).  Included medicines are:
 

Omeprazole oral powder for suspension is BLUE (on recommendation of a specialist) 

  • ONLY for children under 10kg and/or with enteral feeding tubes (less than 8Fr) in place.
  • Consider using the higher strength preparation, 20mg/5ml as proportion of sodium,  potassium and preservatives per dose is less. 
  • Switch to alternative PPI as per algorithm when enteral feeding tube is removed or larger gauge used

Omeprazole dispersible tablets are GREEN

  • 1st line treatment option in children unable to swallow omeprazole capsules.
  • Mezzopram® brand is preferred due to the smaller granule sizes. If Mezzopram® is out of stock or unavailable Losec Mups® should be used as an alternative.
  • Disperse the tablets in water, then mix with orange/apple/ pineapple juice, apple sauce or yoghurt 

Omeprazole capsules are GREEN

  • 1st line treatment option in children who are able to swallow capsules; OR
  • For children who cannot swallow capsules, most capsules can be opened (licensed) and mixed with water or a slightly acidic fluid e.g. fruit juice, apple sauce

Lansoprazole capsules are GREEN 

  • 2nd line treatment option in children who are able to swallow capsules
  • For children who cannot swallow capsules, some capsules are licensed to be opened and have their contents mixed with water, apple/tomato juice or sprinkled on soft food (e.g. yoghurt, apple puree)

Lansoprazole orodispersible tablets are GREEN

  • 2nd line treatment option in children unable to swallow omeprazole or lansoprazole capsules.
  • Oro-dispersible tablets disperse in the mouth to release gastro-resistant granules. Lansoprazole is NOT absorbed sublingually. The gastro-resistant granules must be swallowed for the medicine to be effective. The FasTabs® can also be administered in apple or orange juice.

Aclomep® powder is RED

  • Only for use by Ashford & St Peters NICU

All other unlicensed oral  PPI suspension preparations should be considered NON-Formulary

Associated BNF Codes

01. Gastro-Intestinal System
01.03.05. Proton pump inhibitors
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More